Anal cancer is a rare yet increasing cancer linked primarily to high-risk HPV strains such as HPV-16 and HPV-18. Key risk factors include weakened immune systems, age over 50, and high-risk sexual ...

Losing British drug giant AstraZeneca from the London Stock Exchange would be a “devastating blow”, Tory former chancellor ...

Cheng was a pioneer in clinical trials for tumour diseases, especially small-cell lung carcinoma A top Chinese oncologist and physician-scientist, Cheng Ying, has died suddenly aged 62, according to ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

The company's share price has received a boost in recent weeks after it was declared the successful bidder for UK small ...

London has struggled for several years to attract big-name IPOs amid a dearth of liquidity and a less favourable regulatory ...

Gilt yields spike on Reeves exit speculation and CEO of AstraZeneca discusses leaving London - Stock markets updates and business news from Wednesday ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

Bengaluru: Global biopharmaceutical company AstraZeneca is investing Rs166 crore to expand its Bengaluru operations, creating 400 new jobs. The upgrad.

AstraZeneca has launched a new Global Hub in Bengaluru, investing Rs 166 crore for AI healthcare solutions. This move aims to advance R&D, IT, and digital health operations, creating 400 new jobs. The ...

Chennai, Jun 26 (PTI) Global bio-pharmaceutical company AstraZeneca has established its state-of-the-art Global Hub in Bengaluru investing Rs 166 crore to focus on development of AI-powered healthcare ...

AstraZeneca British-Swedish drugmaker AstraZeneca said on June 26 it is doubling down on India’s innovation potential with a Rs 166 crore investment to expand its Global Hub in Bengaluru.